Jelly Pills produces chewable gummy supplements designed to improve user experience and adherence by replacing traditional pills and capsules. The company emphasizes vegan, organic, gluten‑free, lactose‑free and cruelty‑free formulations. Founded in 2020 by brothers Antón and Quim Roig, the founders draw on a family background in the pharmaceutical and supplements industry. Since launch the startup has sold more than 25 million gummies across markets including Portugal, Germany, France, Italy and the U.K. Jelly Pills positions itself at the intersection of health technology and consumer supplements. Following the new financing, the company plans international expansion with specific ambition to enter the U.S. market. The recent capital injection supports scaling operations and distribution into new global markets.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2024